SenzaGen: SEK1.5m grant from RIFM - Redeye

Redeye endorses SenzaGen’s continued collaboration with RIFM. The company received a SEK1.5m grant to conduct tests using the GARDskin Dose-Response method. We view this development positively, given that RIFM's members include major cosmetics companies, which could have a potential interest in SenzaGen's offering.

Länk till analysen i sin helhet: https://www.redeye.se/research/1018201/senzagen-sek1-5m-grant-from-rifm?utm_source=finwire&utm_medium=RSS